Home » Topics » Disease categories and therapies » Urology

Urology
RSS

AEterna completes enrollment in phase III study of LHRH antagonist cetrorelix in BPH

Oct. 7, 2008

Kringle files IND with FDA for phase I clinical trial of recombinant human HGF in renal disease

Oct. 6, 2008

Ranbaxy patents novel muscarinic receptor antagonists

Sep. 29, 2008

EMEA expands orphan medicinal product status for Neo-Bladder Augment

Sep. 25, 2008

Recent efficacy and safety results presented from a phase II NX-1207 study in LUTS-BPH

Sep. 19, 2008

Recent Biogen Idec patents report novel antifibrotic agents

Sep. 19, 2008

New treatment options for urinary incontinence described in recent Toray patent

Sep. 9, 2008

Protox completes enrollment in phase II trial of PRX-302 in BPH

Sep. 9, 2008

Ikaria acquires North American rights to Lucassin for HRS from Orphan Therapeutics

Sep. 4, 2008

Novel spirofuran potassium channel openers designed for urinary incontinence

Sep. 3, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...